vs
Side-by-side financial comparison of USANA HEALTH SCIENCES INC (USNA) and Walker & Dunlop, Inc. (WD). Click either name above to swap in a different company.
Walker & Dunlop, Inc. is the larger business by last-quarter revenue ($340.0M vs $226.2M, roughly 1.5× USANA HEALTH SCIENCES INC). USANA HEALTH SCIENCES INC runs the higher net margin — 0.1% vs -12.9%, a 13.0% gap on every dollar of revenue. On growth, Walker & Dunlop, Inc. posted the faster year-over-year revenue change (-0.4% vs -10.0%). Over the past eight quarters, Walker & Dunlop, Inc.'s revenue compounded faster (22.1% CAGR vs -0.4%).
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
Walker & Dunlop, Inc. is one of the largest commercial real estate finance and advisory services firms in the United States and internationally.
USNA vs WD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $226.2M | $340.0M |
| Net Profit | $180.0K | $-13.9M |
| Gross Margin | 78.2% | — |
| Operating Margin | 1.7% | -17.2% |
| Net Margin | 0.1% | -12.9% |
| Revenue YoY | -10.0% | -0.4% |
| Net Profit YoY | -74.0% | -131.0% |
| EPS (diluted) | $-0.10 | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $226.2M | $340.0M | ||
| Q3 25 | $213.7M | $337.7M | ||
| Q2 25 | $235.8M | $319.2M | ||
| Q1 25 | $249.5M | $237.4M | ||
| Q4 24 | $213.6M | $341.5M | ||
| Q3 24 | $200.2M | $292.3M | ||
| Q2 24 | $212.9M | $270.7M | ||
| Q1 24 | $227.8M | $228.1M |
| Q4 25 | $180.0K | $-13.9M | ||
| Q3 25 | $-6.5M | $33.5M | ||
| Q2 25 | $9.7M | $34.0M | ||
| Q1 25 | $9.4M | $2.8M | ||
| Q4 24 | $4.5M | $44.8M | ||
| Q3 24 | $10.6M | $28.8M | ||
| Q2 24 | $10.4M | $22.7M | ||
| Q1 24 | $16.5M | $11.9M |
| Q4 25 | 78.2% | — | ||
| Q3 25 | 77.2% | — | ||
| Q2 25 | 78.7% | — | ||
| Q1 25 | 79.0% | — | ||
| Q4 24 | 82.0% | — | ||
| Q3 24 | 80.4% | — | ||
| Q2 24 | 81.1% | — | ||
| Q1 24 | 81.1% | — |
| Q4 25 | 1.7% | -17.2% | ||
| Q3 25 | 0.6% | 13.6% | ||
| Q2 25 | 7.1% | 14.5% | ||
| Q1 25 | 6.3% | 2.2% | ||
| Q4 24 | 3.8% | 15.3% | ||
| Q3 24 | 7.8% | 12.8% | ||
| Q2 24 | 8.4% | 10.4% | ||
| Q1 24 | 10.8% | 6.0% |
| Q4 25 | 0.1% | -12.9% | ||
| Q3 25 | -3.1% | 9.9% | ||
| Q2 25 | 4.1% | 10.6% | ||
| Q1 25 | 3.8% | 1.2% | ||
| Q4 24 | 2.1% | 13.1% | ||
| Q3 24 | 5.3% | 9.9% | ||
| Q2 24 | 4.9% | 8.4% | ||
| Q1 24 | 7.3% | 5.2% |
| Q4 25 | $-0.10 | $-0.41 | ||
| Q3 25 | $-0.36 | $0.98 | ||
| Q2 25 | $0.52 | $0.99 | ||
| Q1 25 | $0.49 | $0.08 | ||
| Q4 24 | $0.23 | $1.32 | ||
| Q3 24 | $0.56 | $0.85 | ||
| Q2 24 | $0.54 | $0.67 | ||
| Q1 24 | $0.86 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.4M | $299.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $1.7B |
| Total Assets | $742.9M | $5.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $158.4M | $299.3M | ||
| Q3 25 | $145.3M | $274.8M | ||
| Q2 25 | $151.3M | $233.7M | ||
| Q1 25 | $179.6M | $181.0M | ||
| Q4 24 | $181.8M | $279.3M | ||
| Q3 24 | $364.9M | $179.8M | ||
| Q2 24 | $332.4M | $208.1M | ||
| Q1 24 | $328.3M | $216.5M |
| Q4 25 | — | $1.7B | ||
| Q3 25 | $528.1M | $1.8B | ||
| Q2 25 | $531.1M | $1.8B | ||
| Q1 25 | $529.8M | $1.7B | ||
| Q4 24 | $532.1M | $1.7B | ||
| Q3 24 | $533.1M | $1.7B | ||
| Q2 24 | $512.2M | $1.7B | ||
| Q1 24 | $500.0M | $1.7B |
| Q4 25 | $742.9M | $5.1B | ||
| Q3 25 | $726.6M | $5.8B | ||
| Q2 25 | $734.5M | $4.7B | ||
| Q1 25 | $746.6M | $4.5B | ||
| Q4 24 | $748.2M | $4.4B | ||
| Q3 24 | $671.3M | $4.6B | ||
| Q2 24 | $631.4M | $4.2B | ||
| Q1 24 | $629.3M | $3.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-664.3M |
| Free Cash FlowOCF − Capex | — | $-680.1M |
| FCF MarginFCF / Revenue | — | -200.0% |
| Capex IntensityCapex / Revenue | — | 4.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-2.2B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-664.3M | ||
| Q3 25 | $-2.0M | $-948.1M | ||
| Q2 25 | $12.2M | $-238.5M | ||
| Q1 25 | $15.5M | $-281.1M | ||
| Q4 24 | $5.8M | $129.4M | ||
| Q3 24 | $29.5M | $-202.0M | ||
| Q2 24 | $8.0M | $-237.8M | ||
| Q1 24 | $17.7M | $38.4M |
| Q4 25 | — | $-680.1M | ||
| Q3 25 | $-5.2M | $-950.4M | ||
| Q2 25 | $7.2M | $-241.0M | ||
| Q1 25 | $12.7M | $-284.7M | ||
| Q4 24 | $4.0M | $116.4M | ||
| Q3 24 | $27.1M | $-204.0M | ||
| Q2 24 | $5.3M | $-241.7M | ||
| Q1 24 | $14.5M | $35.2M |
| Q4 25 | — | -200.0% | ||
| Q3 25 | -2.4% | -281.5% | ||
| Q2 25 | 3.0% | -75.5% | ||
| Q1 25 | 5.1% | -120.0% | ||
| Q4 24 | 1.9% | 34.1% | ||
| Q3 24 | 13.6% | -69.8% | ||
| Q2 24 | 2.5% | -89.3% | ||
| Q1 24 | 6.4% | 15.4% |
| Q4 25 | — | 4.6% | ||
| Q3 25 | 1.5% | 0.7% | ||
| Q2 25 | 2.1% | 0.8% | ||
| Q1 25 | 1.1% | 1.5% | ||
| Q4 24 | 0.8% | 3.8% | ||
| Q3 24 | 1.2% | 0.7% | ||
| Q2 24 | 1.3% | 1.4% | ||
| Q1 24 | 1.4% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | -28.34× | ||
| Q2 25 | 1.27× | -7.02× | ||
| Q1 25 | 1.65× | -102.07× | ||
| Q4 24 | 1.29× | 2.89× | ||
| Q3 24 | 2.78× | -7.01× | ||
| Q2 24 | 0.77× | -10.49× | ||
| Q1 24 | 1.07× | 3.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
